Cargando…

Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans

Understanding antibody-based SARS-CoV-2 immunity is critical for overcoming the COVID-19 pandemic and informing vaccination strategies. We evaluated SARS-CoV-2 antibody dynamics over 10 months in 963 individuals who predominantly experienced mild COVID-19. Investigating 2,146 samples, we initially d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vanshylla, Kanika, Di Cristanziano, Veronica, Kleipass, Franziska, Dewald, Felix, Schommers, Philipp, Gieselmann, Lutz, Gruell, Henning, Schlotz, Maike, Ercanoglu, Meryem S., Stumpf, Ricarda, Mayer, Petra, Zehner, Matthias, Heger, Eva, Johannis, Wibke, Horn, Carola, Suárez, Isabelle, Jung, Norma, Salomon, Susanne, Eberhardt, Kirsten Alexandra, Gathof, Birgit, Fätkenheuer, Gerd, Pfeifer, Nico, Eggeling, Ralf, Augustin, Max, Lehmann, Clara, Klein, Florian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090990/ https://www.ncbi.nlm.nih.gov/pubmed/33984285 http://dx.doi.org/10.1016/j.chom.2021.04.015

Ejemplares similares

Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG
por: Eberhardt, Kirsten Alexandra, et al.
Publicado: (2021)

No substantial preexisting B cell immunity against SARS-CoV-2 in healthy adults
por: Ercanoglu, Meryem Seda, et al.
Publicado: (2022)

Evaluation of a Rapid Antigen Test To Detect SARS-CoV-2 Infection and Identify Potentially Infectious Individuals
por: Korenkov, Michael, et al.
Publicado: (2021)

Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study
por: Augustin, Max, et al.
Publicado: (2021)

Probabilities of developing HIV-1 bNAb sequence features in uninfected and chronically infected individuals
por: Kreer, Christoph, et al.
Publicado: (2023)

CD34T+ Humanized Mouse Model to Study Mucosal HIV-1 Transmission and Prevention
por: Vanshylla, Kanika, et al.
Publicado: (2021)

Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers
por: Vanshylla, Kanika, et al.
Publicado: (2022)

Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
por: Kreer, Christoph, et al.
Publicado: (2020)

Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
por: Kreer, Christoph, et al.
Publicado: (2020)

SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patterns
por: Gruell, Henning, et al.
Publicado: (2022)

Lactobacilli Expressing Broadly Neutralizing Nanobodies against HIV-1 as Potential Vectors for HIV-1 Prophylaxis?
por: Kalusche, Sarah, et al.
Publicado: (2020)

mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant
por: Gruell, Henning, et al.
Publicado: (2022)

Durability of omicron-neutralising serum activity after mRNA booster immunisation in older adults
por: Vanshylla, Kanika, et al.
Publicado: (2022)

Predicting in vivo escape dynamics of HIV-1 from a broadly neutralizing antibody
por: Meijers, Matthijs, et al.
Publicado: (2021)

Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections
por: Tober-Lau, Pinkus, et al.
Publicado: (2022)

Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody
por: Schommers, Philipp, et al.
Publicado: (2020)

Dynamics and durability of HIV-1 neutralization are determined by viral replication
por: Schommers, Philipp, et al.
Publicado: (2023)

Safe and effective pool testing for SARS-CoV-2 detection
por: Wunsch, Marie, et al.
Publicado: (2021)

Antibody-mediated neutralization of SARS-CoV-2
por: Gruell, Henning, et al.
Publicado: (2022)

Design of an optimal combination therapy with broadly neutralizing antibodies to suppress HIV-1
por: LaMont, Colin, et al.
Publicado: (2022)

Immunological fingerprint in coronavirus disease-19 convalescents with and without post-COVID syndrome
por: Augustin, Max, et al.
Publicado: (2023)

SARS-CoV-2-specific cellular response following third COVID-19 vaccination in patients with chronic lymphocytic leukemia
por: Mellinghoff, Sibylle C., et al.
Publicado: (2022)

Neutralisation sensitivity of the SARS-CoV-2 omicron BA.2.75 sublineage
por: Gruell, Henning, et al.
Publicado: (2022)

15-month post-COVID syndrome in outpatients: Attributes, risk factors, outcomes, and vaccination status - longitudinal, observational, case-control study
por: Augustin, Max, et al.
Publicado: (2023)

CXCR3 Expression Pattern on CD4+ T Cells and IP-10 Levels with Regard to the HIV-1 Reservoir in the Gut-Associated Lymphatic Tissue
por: Augustin, Max, et al.
Publicado: (2022)

RNAemia Corresponds to Disease Severity and Antibody Response in Hospitalized COVID-19 Patients
por: Eberhardt, Kirsten Alexandra, et al.
Publicado: (2020)

CMV-IgG pre-allogeneic hematopoietic stem cell transplantation and the risk for CMV reactivation and mortality
por: Eberhardt, Kirsten Alexandra, et al.
Publicado: (2023)

Case Report: Clinical Management of a Patient With Metastatic Non-Small Cell Lung Cancer Newly Receiving Immune Checkpoint Inhibition During Symptomatic COVID-19
por: Mellinghoff, Sibylle C., et al.
Publicado: (2021)

Plasma exchange with COVID-19 convalescent plasma in a patient with severe ANCA-associated vasculitis and COVID-19 pneumonia after rituximab therapy
por: Kochanek, Matthias, et al.
Publicado: (2021)

Gamma heavy chain disease in a patient with rheumatoid arthritis – a laboratory evaluation
por: Johannis, Wibke, et al.
Publicado: (2012)

Long‐lived macrophage reprogramming drives spike protein‐mediated inflammasome activation in COVID‐19
por: Theobald, Sebastian J, et al.
Publicado: (2021)

Molecular Characterization and Clinical Description of Non-Polio Enteroviruses Detected in Stool Samples from HIV-Positive and HIV-Negative Adults in Ghana
por: Di Cristanziano, Veronica, et al.
Publicado: (2020)

Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19
por: Thibeault, Charlotte, et al.
Publicado: (2023)

Long-term immunogenicity of BNT162b2 vaccination in older people and younger health-care workers
por: Tober-Lau, Pinkus, et al.
Publicado: (2021)

Development and characterization of an indirect ELISA to detect SARS-CoV-2 spike protein-specific antibodies
por: Krähling, Verena, et al.
Publicado: (2021)

C-Reactive Protein and Lymphocyte-to-Monocyte Ratio Predict Recurrence in Stage III Melanoma Patients with Microscopic Sentinel Lymph Node Metastasis
por: Schildbach, Viktoria Anna Sophie, et al.
Publicado: (2023)

Immune Responses to SARS-CoV-2 Infection and Vaccination in Dialysis Patients and Kidney Transplant Recipients
por: Affeldt, Patrick, et al.
Publicado: (2021)

Grb2 and GRAP connect the B cell antigen receptor to Erk MAP kinase activation in human B cells
por: Vanshylla, Kanika, et al.
Publicado: (2018)

Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection
por: Halwe, Sandro, et al.
Publicado: (2021)

SARS-CoV-2–neutralizing antibody treatment in patients with COVID-19 and immunodeficiency due to B-cell non-Hodgkin lymphoma
por: Malin, Jakob J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eu2kfcq4gooreigvcc6qj7dfnf